Health
Jacobio Completes First Dose of IIa Clinical Trial of JAB-21822 on KRAS G12C and STK11 Co-mutation in China
BEIJING, Sept. 1, 2022 /PRNewswire/ -- JacobioPharma (1167.HK) announced that the company has dosed the first non-small cell lung cancer (NSCLC) patient with KRAS G12C and STK11 co-mutation in the Phase IIa trial of KRAS G12C inhibitor JAB-21822 inChina. JAB-21822 is a KRAS G12C inhibitor inde...
2022-09-02 17:14
2061
Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022
* Non-clinical studies explored the potent anti-fibrotic and anti-inflammatory efficacy of BBT-301 and BBT-209 for IPF treatment * Company enhances its strategic focus on fibrotic diseases inclusive of IPF with 1 clinical asset and 2 non-clinical assets BOSTON and SEONGNAM, South Korea ,Sept. ...
2022-09-02 09:41
1765
Pxierra is launching world's first non-contact heart rate & breathe rate measurement AI baby monitor
NEW YORK, Sept. 1, 2022 /PRNewswire/ -- Pxierra is excited to announce the launch of its innovative AI Baby monitor. This new device is designed to provide non-contact heart rate and breathing rate measurement, making it easier and more convenient for parents to keep track of their newborns' vita...
2022-09-01 21:00
1947
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management
SHANGHAI, Sept 1, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patient management service, today a...
2022-09-01 19:30
2798
The ECO-Friendly Anti-nausea and Vomiting wristband: Emeterm PLUS
VANCOUVER, BC, Aug. 31, 2022 /PRNewswire/ -- WAT Medical is thrilled to introduce its latest innovative technology that would help the millions of people who suffer from nausea and vomiting, the EmeTerm Plus, while also developing an eco-friendly roadmap that would benefit future innovations. The...
2022-09-01 01:15
1980
AI Startup AESOP Raises $3M to Tackle Medical and Billing Errors
SAN FRANCISCO, Aug. 31, 2022 /PRNewswire/ -- Digital health startup AESOP
Technology
2022-09-01 00:00
2156
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey
CRANBURY, N.J., Aug. 31, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), today announced the release of its GMP phase I drug substance clinical manufacturing facility, MFG18, inCranbury, New Jersey...
2022-08-31 20:00
2340
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.
Marks the First Entry of Biokangtai's 13-valent Pneumococcal Vaccine into Southeast Asian Market SHENZHEN, China, Aug. 31, 2022 /PRNewswire/ -- On August 30, Beijing Minhai Biotechnology Co., Ltd. held a signing ceremony with Phil. Pharmawealth, Inc. for their cooperation in jointly promoting th...
2022-08-31 17:05
1773
Nreal Air AR Glasses Receive TÜV Rheinland Eye Comfort (AR) Certification
SHANGHAI , Aug. 30, 2022 /PRNewswire/ -- On August 22, 2022, TÜV Rheinland Greater China ("TÜV Rheinland") awarded the Eye Comfort (AR) Certification for Nreal's AR glasses, Nreal Air, ahead of the device's official launch inChina. The bestowal of TÜV Rheinland's highest-level display certificati...
2022-08-31 10:27
2081
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance
YONGIN, South Korea and AUSTIN, Texas, Aug. 30 2022 /PRNewswire/ -- GC Biopharma (006280.KS) and Speragen today announced that a joint Externally Led - Patient-Focused Drug Development (EL-PFDD) meeting hosted by SSADH Association and attended by the U.S. FDA and other stakeholders was held to a...
2022-08-31 08:33
1950
Tycoon Group Announces 2022 Interim Results
Dual-Channel Drive Strategy Brought a Record-High Revenue of 588 Million & Rebound with 22.8 Million Profit The Group Continues to Explore the Blue Ocean Market in China Results Highlights * The Group taking the lead in developing cross-border e-commerce business and adopting an online and of...
2022-08-30 22:47
3837
Waterdrop receives the NBD "2022 Green Practice Pioneering Projects"
BEIJING, Aug. 30, 2022 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or "the Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, announced that Waterdrop became a finalist for "2022 Green Practice Pioneering Projects", wh...
2022-08-30 22:00
2901
Fosun Pharma Announces 2022 Interim Results
Stable Revenue Growth and Recurring Income, Elevating the Revenue Contribution of New Products, and Accelerating International Layout Highlights: * Revenue for the first half of 2022 amounted to RMB21,340 million, an increase of 25.88% YOY; * Net profit (after extraordinary gain or loss) att...
2022-08-30 20:28
3458
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022
* Seven key clinical milestones achieved year-to-date, including positive data readouts for lemzoparlimab, uliledlimab, and TJ-CD4B * Lemzoparlimab is on track for Phase 3 study for 1L MDS * Amendment to the global partnership with AbbVie for certain new CD47 antibodies currently in developm...
2022-08-30 18:00
2353
Kintor Announces 2022 Interim Results and Recent Business Update
SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma" or "the Company", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced its 2022 interim results and released an update on i...
2022-08-30 00:19
3435
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Aug. 29, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...
2022-08-29 21:00
2401
NEXT-GENERATION EGFR TKI H002 FROM REDCLOUD BIO COMPLETES FIRST DOSE IN NON-SMALL CELL LUNG CANCER
* H002 is a precision therapeutic candidate for the treatment of NSCLC, with broad spectrum and high selectivity against multiple EGFR mutations including those with EGFR C797S mutation. * RedCloud Bio has initiated H002 Phase I/IIa clinical studies in both China and US. SHANGHAI, Aug. 29, 20...
2022-08-29 19:30
2120
Porton Advanced and Royaltech Announce Strategic Collaboration to Accelerate the Development of Bacterial Drugs and mRNA Drugs
SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- On August 19, 2022, Porton Advanced Solutions. (hereinafter referred to as Porton Advanced) announced a strategic cooperation with Suzhou Royaltech Med Co., Ltd. (hereinafter referred to as Suzhou Royaltech).This strategic collaboration will further in...
2022-08-29 12:23
1947
First Vietnam's natural mineral water brand provides perfect alkalinity pH = 9.0 from the premium unique mineral source of Danh Thanh
HO CHI MINH CITY, Vietnam, Aug. 28, 2022 /PRNewswire/ -- Owning one of the best natural mineral water sources in the country, Khanh Hoa Mineral Water Joint Stock Company (formerly known as Danh Thanh Mineral Water Enterprise), a subsidiary company of F.I.T Group, has launched a series of healthy ...
2022-08-29 10:00
2645
Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation
SHANGHAI, Aug. 27, 2022 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals ( Shanghai) Co., Ltd. (Sanyou) and Shanghai KangaBio Co., Ltd. (KangaBio) have reached an antibody drug licensing agreement, regarding a proprietary monoclonal antibody drug developed by Sanyou, which grants KangaBio an e...
2022-08-28 08:00
4103
Week's Top Stories
Most Reposted
Infobip recognized as RCS Business Messaging Leader by Juniper Research
[Picked up by 331 media titles]
2024-11-05 18:06
Mastercard goes OTP-free in APAC for faster, safer online transactions
[Picked up by 326 media titles]
2024-11-06 09:00Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Mastercard launches Pay Local, enabling Asia's digital wallet providers to process card payments from more than 2 billion Mastercard cardholders
[Picked up by 317 media titles]
2024-11-05 09:00XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
[Picked up by 277 media titles]
2024-11-07 11:34
Most Read
Mastercard goes OTP-free in APAC for faster, safer online transactions
2024-11-06 09:00
12353
Infobip recognized as RCS Business Messaging Leader by Juniper Research
2024-11-05 18:06
9441
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
8557
